Parallel session 10:00 - 12:00
Complex drug products: new insights in development, production & characterization
Recent developments in innovative technologies like Advanced Therapy Medicinal Products (ATMPs) and Nano-medicines provide new opportunities to address the increasing demands of an aging population, as well as for diseases with high unmet medical needs.
Despite recent innovations and considerable research and development efforts there is clear mismatch between these research and development efforts and the number of approved products in the European Union. The road from development to approval poses many challenges for scientists, developers and regulators and asks for collaborative opportunities to meet those challenges, which we will discuss in this session.
How to adapt to new technologies and ATMP’s: a CMO’s view
PhD - BioConnection
Assuring quality of non-biological complex drugs (NBCDs): EDQM and the European Pharmacopoeia
Prof - Chair of the NBC working party at the European Directorate for the Quality of Medicines & Health Care (EDQM)
Development of a personalised, cellular product in hemato-oncology; risks and opportunities
PhD, MD - CMO Kiadis Pharma
How to bring ATMPs to the patient: a funders perspective
Programme Manager ‘Translational Research and International Programs' at ZonMw